ES2149196T3 - Metodos y composiciones para tratar infecciones utilizando (r)-lomefloxacina opticamente pura. - Google Patents

Metodos y composiciones para tratar infecciones utilizando (r)-lomefloxacina opticamente pura.

Info

Publication number
ES2149196T3
ES2149196T3 ES93900612T ES93900612T ES2149196T3 ES 2149196 T3 ES2149196 T3 ES 2149196T3 ES 93900612 T ES93900612 T ES 93900612T ES 93900612 T ES93900612 T ES 93900612T ES 2149196 T3 ES2149196 T3 ES 2149196T3
Authority
ES
Spain
Prior art keywords
lomefloxacin
compositions
methods
optically pure
treat infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900612T
Other languages
English (en)
Inventor
James W Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ES2149196T3 publication Critical patent/ES2149196T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN METODOS Y COMPOSICIONES QUE EMPLEAN (R)-ISOMERO DE LOMEFLOXACINA OPTICAMENTE PURA. ESTE COMPUESTO ES UNA POTENTE DROGA PARA EL TRATAMIENTO DE INFECCIONES U OTRAS ENFERMEDADES QUE PRECISAN ANTIBIOTICOS EVITANDO LA NECESIDAD DE LOS ADVERSOS EFECTOS ASOCIADOS A LA MEZCLA RACEMICA DE LOMEFLOXACINA.
ES93900612T 1991-11-27 1992-11-25 Metodos y composiciones para tratar infecciones utilizando (r)-lomefloxacina opticamente pura. Expired - Lifetime ES2149196T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80066891A 1991-11-27 1991-11-27
PCT/US1992/010144 WO1993010786A1 (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (r)-lomefloxacin

Publications (1)

Publication Number Publication Date
ES2149196T3 true ES2149196T3 (es) 2000-11-01

Family

ID=25179035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900612T Expired - Lifetime ES2149196T3 (es) 1991-11-27 1992-11-25 Metodos y composiciones para tratar infecciones utilizando (r)-lomefloxacina opticamente pura.

Country Status (11)

Country Link
EP (1) EP0661974B1 (es)
JP (1) JPH07501546A (es)
AT (1) ATE196085T1 (es)
AU (2) AU3223693A (es)
CA (1) CA2124444A1 (es)
DE (1) DE69231423T2 (es)
DK (1) DK0661974T3 (es)
ES (1) ES2149196T3 (es)
GR (1) GR3034919T3 (es)
PT (1) PT661974E (es)
WO (1) WO1993010786A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) * 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
JPS60190777A (ja) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd 光学活性な６，８−ジフルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法

Also Published As

Publication number Publication date
CA2124444A1 (en) 1993-06-10
DE69231423T2 (de) 2001-01-04
GR3034919T3 (en) 2001-02-28
DK0661974T3 (da) 2000-10-16
AU3223693A (en) 1993-06-28
PT661974E (pt) 2001-02-28
ATE196085T1 (de) 2000-09-15
EP0661974B1 (en) 2000-09-06
JPH07501546A (ja) 1995-02-16
WO1993010786A1 (en) 1993-06-10
EP0661974A4 (en) 1994-08-29
EP0661974A1 (en) 1995-07-12
AU1515297A (en) 1997-05-22
DE69231423D1 (de) 2000-10-12

Similar Documents

Publication Publication Date Title
ES2042520T3 (es) Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
DK91690A (da) Anvendelse af adamantan-derivater til fremstilling af terapeutiske praeparater til behandling af ischaemi
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
ES2143132T3 (es) Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion.
DK52487A (da) Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser
ES2062292T3 (es) Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
BR9611276A (pt) Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ES2149196T3 (es) Metodos y composiciones para tratar infecciones utilizando (r)-lomefloxacina opticamente pura.
ES2123004T3 (es) Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.
PT91006A (pt) Processo para a preparacao de um novo sal de estroncio
PT91745A (pt) Processo para a preparacao de uma composicao contendo acidos da bilis uteis para o tratamento de infeccoes virais
DE69109314D1 (de) Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen.
NO873934L (no) Saarhelende serotoninantagonistisk forbindelse.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
DK235089D0 (da) Anvendelse af aetiprotimodae til fremstilling af et laegemiddel imod virusinfektioner
ES2035829T3 (es) Procedimiento para obtener un preparado farmaceutico para el tratamiento de infecciones bactertianas.
HUT48265A (en) Process for producing phosphorous-containing 2-isoxazolines and isoxazoles and pharmaceutical compositions containing them or theyr salts as active components
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661974

Country of ref document: ES